Skip to main content

Table 1 Baseline characteristics of the study cases

From: Prevalence of celiac-related antibodies and its impact on metabolic control in Egyptian children with type 1 diabetes mellitus

Variable

Patients

(N = 200)

Patients’ subgroups

Patients with positive tests (n = 11)

Patients with negative tests (n = 189)

p-value

Age/ year (Mean ± SD)

9.39 ± 2.72

8.41 ± 2.67

9.44 ± 2.72

0.222

Sex (N. %):

Male

Female

92(46%)

108(54%)

3(27.27%)

8(72.73%)

89(47.09%)

100(52.91%)

0.200

Duration of type 1 diabetes/year Median (IQ range)

3.0 (2–4)

2.0 (1–4)

3.0 (2–4)

0.293

Age of diabetic onset/ year (Mean ± SD)

7.78 ± 2.7

5.73 ± 2.66

7.9 ± 2.66

0.009**

Age of diabetic onset (N. %)

≤ 5 years

>5 years

23(11.5%)

177(88.5%)

4(36.4%)

7(63.6%)

19(10.1%)

170(89.9%)

0.029*

Family history of type 1 diabetes

   

0.473

(N. %)

Yes

No

34(17%)

166 (83%)

1(9.09%)

10 (90.9%)

33(17.46%)

156 (82.54%)

 

Hypoglycemic attacks (N. %)

Yes

No

19(9.5%)

181 (90.5%)

5(45.45%)

6 (54.5%)

14(7.41%)

175 (92.6%)

< 0.001*

Recurrent DKA (N. %)

Yes

No

30(15%)

170 (85%)

5(45.45%)

6 (54.5%)

25(13.23%)

164 (86.8%)

0.004*

Insulin dose U/kg/day (Mean ± SD)

0.97 ± 0.16

1.15 ± 0.24

0.96 ± 0.15

< 0.001*

Weight Z score (Mean ± SD)

-1.29 ± 0.57

-1.14 ± 1.36

-1.3 ± 0.49

0.354

Height Z score (Mean ± SD)

-1.23 ± 0.53

-1.59 ± 0.55

-1.21 ± 0.52

0.018*

BMI Z score (Mean ± SD)

-0.81 ± 0.68

-0.89 ± 0.48

-0.81 ± 0.69

0.681

  1. -P-value between patients with positive tests and patients with negative tests. - *Statistically significant predictor (p < 0.05). -DKA: Diabetic ketoacidosis – BMI: Body mass index